Jolt Health To Acquire HCQ Transdermal Patch Technology

FDA Approved and Viability to Address Underserved Lupus, Rheumatoid Arthritis and Malaria market, forecast to be worth $6 Billion USD by 2027* VANCOUVER, BC / ACCESSWIRE / May 6, 2024 / Jolt Health Inc. ("JOLT" and or "the Company") …
Jetzt den vollständigen Artikel lesen